Image of coronavirus and syringe to show Pfizer and BioNTech announce COVID vaccine 90% effective

Pfizer and BioNTech announce COVID vaccine 90% effective

Pfizer Inc and BioNTech SE have announced that their COVID vaccine candidate was found to be more than 90% effective in preventing COVID-19 in...
Over 1,000 jobs for NI pharmacy sector in the next five years

Over 1,000 jobs for NI pharmacy sector in the next five years

More than 1,100 additional roles in the pharmacy sector in Northern Ireland will be required over the next five years. The opportunities – which...
NICE recommends upadacitinib as treatment for severe rheumatoid arthritis

NICE recommends upadacitinib as treatment for severe rheumatoid arthritis

The National Institute for Health and Care Excellence (NICE) has issued a positive Final Appraisal Determination (FAD) recommending upadacitinib, a once-daily oral therapy, for...
Same-day emergency medicines supply service launched in London

Same-day emergency medicines supply service launched in London

A new same-day emergency medicines supply service that will cover hospitals and clinics in Central London locations has been launched. The service aims to...
SMC accepts immunotherapy BAVENCIO® (avelumab) for treatment of kidney cancer

SMC accepts BAVENCIO® (avelumab) for treatment of kidney cancer

An announcement from Merck and Pfizer confirms that the Scottish Medicines Consortium (SMC) has accepted the immunotherapy BAVENCIO® (avelumab) for use within NHS Scotland...
National programme launched to develop and progress oncology projects

National programme launched to develop and progress oncology projects

A national programme has been launched, with some of the biggest names in UK cancer research and clinical excellence and four major global pharmaceutical...
Pf Awards 2021 virtual logo to show Pf Awards 2021 are open for entries

Enter the Pf Awards 2021 today

The Pf Awards 2021 are open for entries! New categories | New candidates | New opportunities to win Would you like to win a national...
Abingdon Health announces new non-executive director and board member

Abingdon Health announces new Non-Executive Director

Mary Tavener has been appointed as Non-Executive Director (NED) and Board member of Abingdon Health with immediate effect. Mary will be the Senior Independent NED...
GlaxoSmithKline's Zejula (niraparib) approved for treatment of ovarian cancer

GlaxoSmithKline’s Zejula (niraparib) approved for treatment of ovarian cancer

The European Commission has approved GlaxoSmithKline's (GSK) Zejula (niraparib), an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, as first-line monotherapy maintenance treatment for adult...
TherapeutAix adds Alderley Analytical and Peak Proteins to its R&D network

TherapeutAix expands R&D network to Alderley Analytical and Peak Proteins

Life sciences consultancy, TherapeutAix, has added contract research organisations (CROs), Alderley Analytical and Peak Proteins to its global R&D network. The partnership will form...

Latest articles

NHS Prescription Tracker Integration

NHS Prescription Tracker Integration

Cegedim Healthcare Solutions, part of the innovative healthcare technology and service company, Cegedim, has delivered the first-to-market integration of the NHS Prescription Tracker within...
COVID-19 and the counterfeit drug crisis

COVID-19 and the counterfeit drug crisis

The threat posed to the pharmaceutical industry by counterfeit drugs medicines is on the rise - and could be set to get worse unless...
Elsevier report identifies emerging areas of research in pancreatic cancer

Elsevier report identifies emerging areas of research in pancreatic cancer

Elsevier has published the findings of a new report on emerging trends in pancreatic cancer research and literature. The report highlights several trending terms...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
COVID-19 and the counterfeit drug crisis

COVID-19 and the counterfeit drug crisis

The threat posed to the pharmaceutical industry by counterfeit drugs medicines is on the rise - and could be set to get worse unless...
Elsevier report identifies emerging areas of research in pancreatic cancer

Elsevier report identifies emerging areas of research in pancreatic cancer

Elsevier has published the findings of a new report on emerging trends in pancreatic cancer research and literature. The report highlights several trending terms...
Virtual clinical trial recruits 67% faster led by NIHR Patient Recruitment Centre

Virtual clinical trial recruits 67% faster led by NIHR Patient Recruitment Centre

A collaboration between one of the NIHR’s new National Patient Recruitment Centres (NPRCs) and UK sponsor company Enteromed has led to rapid recruitment to...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription